Recent advances in preventing neurodegenerative diseases.

Abstract

The worldwide health-care burden of neurodegenerative diseases is on the rise-a crisis created through a combination of increased caseload and lack of effective treatments. The limitations of pharmacotherapy in these disorders have led to an urgent shift toward research and clinical trials for the development of novel compounds, interventions, and methods that target shared features across the spectrum of neurodegenerative diseases. Research targets include neuronal cell death, mitochondrial dysfunction, protein aggregation, and neuroinflammation. In the past few years, there has been a growth in understanding of the pathophysiologic mechanisms of neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, and Huntington's disease. This increase in knowledge has led to the discovery of numerous novel neuroprotective therapeutic targets. In this context, we reviewed and summarized recent advancements in neuroprotective strategies in neurodegenerative diseases.

• Authors: Shih-Ching Chou, Akanksha Aggarwal, Valina L Dawson, Ted M Dawson, Tae-In Kam
• Journal: Faculty reviews (Fac Rev) Vol. 10 Pg. 81 ( 2021) ISSN: 2732-432X [Electronic] England
• PMID: 35028646 (Publication Type: Journal Article, Review)
• Copyright: Copyright: © 2021 Dawson TM et al.